145 related articles for article (PubMed ID: 32809978)
1. Metastatic Melanoma Negative for 5 Melanocytic Markers, Complete Regressed Primary Cutaneous Melanoma, and Melanoma-Associated Leukoderma in the Same Patient.
Ramos-Rodríguez C; García-Arpa M; Relea-Calatayud MF; González-López L; Romero-Aguilera G
Am J Dermatopathol; 2020 Dec; 42(12):956-960. PubMed ID: 32809978
[TBL] [Abstract][Full Text] [Related]
2. Lymph node melanosis in a patient with metastatic melanoma of unknown primary.
Malafronte P; Sorrells T
Arch Pathol Lab Med; 2009 Aug; 133(8):1332-4. PubMed ID: 19653733
[TBL] [Abstract][Full Text] [Related]
3. Metastatic Malignant Melanoma With Complete Loss of Differentiation Markers (Undifferentiated/Dedifferentiated Melanoma): Analysis of 14 Patients Emphasizing Phenotypic Plasticity and the Value of Molecular Testing as Surrogate Diagnostic Marker.
Agaimy A; Specht K; Stoehr R; Lorey T; Märkl B; Niedobitek G; Straub M; Hager T; Reis AC; Schilling B; Schneider-Stock R; Hartmann A; Mentzel T
Am J Surg Pathol; 2016 Feb; 40(2):181-91. PubMed ID: 26448190
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous tumoural melanosis: a presentation of complete regression of cutaneous melanoma.
Ching D; Amini E; Harvey NT; Wood BA; Mesbah Ardakani N
Pathology; 2019 Jun; 51(4):399-404. PubMed ID: 31023480
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of BRAF V600E mutational status in capsular nevi of sentinel lymph nodes in patients with primary cutaneous melanoma.
Siroy AE; Aung PP; Torres-Cabala CA; Tetzlaff MT; Nagarajan P; Milton DR; Curry JL; Ivan D; Prieto VG
Hum Pathol; 2017 Jan; 59():48-54. PubMed ID: 27666765
[TBL] [Abstract][Full Text] [Related]
6. Tumoral Melanosis in the Setting of Targeted Immunotherapy for Metastatic Melanoma-A Single Institutional Experience and Literature Review.
Jurgens A; Guru S; Guo R; Brewer J; Bridges A; Jakub J; Comfere N
Am J Dermatopathol; 2021 Jan; 43(1):9-14. PubMed ID: 32149829
[TBL] [Abstract][Full Text] [Related]
7. An unusual case of desmoplastic melanoma containing an osteoclast-like giant cell-rich nodule.
Houang M; Castillo C; La Marca S; Combemale P; Wang Q; Paindavoine S; Pissaloux D; de la Fouchardiere A
Am J Dermatopathol; 2015 Apr; 37(4):299-304. PubMed ID: 24999544
[TBL] [Abstract][Full Text] [Related]
8. A metastatic melanoma with an unusual immunophenotypic profile.
Gao Z; Stanek A; Chen S
Am J Dermatopathol; 2007 Apr; 29(2):169-71. PubMed ID: 17414440
[TBL] [Abstract][Full Text] [Related]
9. BRAF-V600 Mutation Heterogeneity in Primary and Metastatic Melanoma: A Study With Pyrosequencing and Immunohistochemistry.
Yaman B; Kandiloğlu G; Akalin T
Am J Dermatopathol; 2016 Feb; 38(2):113-20. PubMed ID: 26630683
[TBL] [Abstract][Full Text] [Related]
10. Aberrant intermediate filament and synaptophysin expression is a frequent event in malignant melanoma: an immunohistochemical study of 73 cases.
Romano RC; Carter JM; Folpe AL
Mod Pathol; 2015 Aug; 28(8):1033-42. PubMed ID: 26022451
[TBL] [Abstract][Full Text] [Related]
11. Microphthalmia transcription factor in the immunohistochemical diagnosis of metastatic melanoma: comparison with four other melanoma markers.
Miettinen M; Fernandez M; Franssila K; Gatalica Z; Lasota J; Sarlomo-Rikala M
Am J Surg Pathol; 2001 Feb; 25(2):205-11. PubMed ID: 11176069
[TBL] [Abstract][Full Text] [Related]
12. Can SOX-10 or KBA.62 Replace S100 Protein in Immunohistochemical Evaluation of Sentinel Lymph Nodes for Metastatic Melanoma?
Vrotsos E; Alexis J
Appl Immunohistochem Mol Morphol; 2016 Jan; 24(1):26-9. PubMed ID: 25611246
[TBL] [Abstract][Full Text] [Related]
13. HMB-45, S-100, NK1/C3, and MART-1 in metastatic melanoma.
Zubovits J; Buzney E; Yu L; Duncan LM
Hum Pathol; 2004 Feb; 35(2):217-23. PubMed ID: 14991540
[TBL] [Abstract][Full Text] [Related]
14. Melanoma arising from a long-standing pigmented trichoblastoma: clinicopathologic study with complementary aCGH/mutational analysis.
Benaïm G; Castillo C; Houang M; Dejardin L; Mateus C; Wang Q; Pissaloux D; Tomasic G; Cribier B; de la Fouchardière A
Am J Dermatopathol; 2014 Aug; 36(8):e146-51. PubMed ID: 24335517
[TBL] [Abstract][Full Text] [Related]
15. Tumoral melanosis after immunotherapy with pembrolizumab - a response sign mimicking melanoma.
Relvas M; Alves F; Mariano A; Cardoso J; Coutinho I
Dermatol Online J; 2020 Oct; 26(10):. PubMed ID: 33147666
[TBL] [Abstract][Full Text] [Related]
16. Lymph node melanosis from a primary cutaneous lesion combining a nodular (tumoral) melanosis and a congenital dermal melanocytic nevus.
Rongioletti F; Pavesi A; Carli C; Parodi A; Fiocca R
Am J Dermatopathol; 2012 Aug; 34(6):653-7. PubMed ID: 22456514
[TBL] [Abstract][Full Text] [Related]
17. Reticulin and NM23 staining in the interpretation of lymph nodal nevus rests.
Kanner WA; Barry CI; Smart CN; Frishberg DP; Binder SW; Wick MR
Am J Dermatopathol; 2013 Jun; 35(4):452-7. PubMed ID: 23694823
[TBL] [Abstract][Full Text] [Related]
18. [Primary melanoma of the bladder. A case report].
Osorio E; Orozco R; Argueta V
Rev Esp Patol; 2018; 51(4):244-247. PubMed ID: 30269776
[TBL] [Abstract][Full Text] [Related]
19. Primary cutaneous signet-ring cell melanoma: a clinico-pathologic and immunohistochemical study of two cases.
Rütten A; Huschka U; Requena C; Rodríguez-Peralto JL; Requena L
Am J Dermatopathol; 2003 Oct; 25(5):418-22. PubMed ID: 14501290
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of melanocytic neoplasms: application of a pan-melanoma antibody cocktail.
Orchard G
Br J Biomed Sci; 2002; 59(4):196-202. PubMed ID: 12572952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
